tiprankstipranks
Trending News
More News >
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Cash flow

Compare
131 Followers

Dermata Therapeutics Cash Flow

DRMA's free cash flow for Q3 2025 was $-1.80M. For the 2025 fiscal year, DRMA's free cash flow was decreased by $-4.75M and operating cash flow was $-1.80M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -11.16M$ -6.41M$ -8.83M$ -5.69M$ -4.03M
Investing Cash Flow
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 6.89M$ 7.61M$ 4.28M$ 15.96M$ 2.57M
End Cash Position
$ 3.16M$ 7.44M$ 6.24M$ 10.80M$ 530.40K
Free Cash Flow
$ -11.16M$ -6.41M$ -8.83M$ -5.69M$ -4.03M
Currency in USD

Dermata Therapeutics Cash Flow